|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12Q 1/68 | (2018.01) |
| (11) | Number of the document | 3198033 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15782109.1 |
| Date of filing the European patent application | 2015-09-18 | |
| (97) | Date of publication of the European application | 2017-08-02 |
| (45) | Date of publication and mention of the grant of the patent | 2022-02-16 |
| (46) | Date of publication of the claims translation | 2022-05-10 |
| (86) | Number | PCT/US2015/050996 |
| Date | 2015-09-18 |
| (87) | Number | WO 2016/048833 |
| Date | 2016-03-31 |
| (30) | Number | Date | Country code |
| 201462056159 P | 2014-09-26 | US |
| (72) |
KARKERA, Jayaprakash , US
PLATERO, Suso Jesus , US
|
| (73) |
Janssen Pharmaceutica NV ,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | FGFR mutantinių genų rinkinių panaudojimas identifikuojant vėžiu sergančius pacientus, kurie reaguos į gydymą FGFR inhibitoriumi |
| USE OF FGFR MUTANT GENE PANELS IN IDENTIFYING CANCER PATIENTS THAT WILL BE RESPONSIVE TO TREATMENT WITH AN FGFR INHIBITOR |
| Payment date | Validity (years) | Amount | |
| 2024-08-20 | 10 | 231.00 EUR |
| 2025-09-18 |